|
⚲
|
| Keyboard |
| Desouza Errol B
✚
|
|
|---|---|
| CIK # | 0001213895 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001213895] | |
| 4 | [0001213895] |
| Form 3/4/5 Subject | 2011 - 2026 |
|---|---|
| Alector LLC | |
| Desouza Errol B | |
| Royalty Pharma PLC | |
| Cyclerion Therapeutics Inc | |
| GYRE Therapeutics Inc | |
| Albireo Pharma Inc |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Alector LLC ALEC
Common Stock
|
2025-06-11 | Grant | 28,700 | $0.00 | |
|
Alector LLC ALEC
Stock Option (right to buy) · derivative
|
2025-06-11 | Grant | 9,450 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2025-05-13 | Grant | 7,614 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2024-06-07 | Grant | 9,293 | $0.00 | |
|
Alector LLC ALEC
Common Stock
|
2024-03-19 | Grant | 41,250 | $0.00 | |
|
Alector LLC ALEC
Stock Option (right to buy) · derivative
|
2024-03-19 | Grant | 19,420 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Common Stock
|
2023-11-30 | Grant | 20,000 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Common Stock
|
2023-11-30 | Grant | 30,000 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2023-06-23 | Grant | 7,747 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2022-06-24 | Grant | 6,328 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Stock Option (Right to Buy) · derivative
|
2022-06-14 | Grant | 20,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-10-01 | Grant | 3,588 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-07-01 | Grant | 3,406 | $0.00 | |
|
Royalty Pharma PLC RPRX
Class A Ordinary Shares
|
2021-06-25 | Grant | 5,726 | $0.00 | |
|
Cyclerion Therapeutics Inc CYCN
Stock Option (Right to Buy) · derivative
|
2021-06-24 | Grant | 10,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Stock Option (Right to Buy) · derivative
|
2021-06-09 | Grant | 14,000 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-04-01 | Grant | 2,926 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2021-01-05 | Grant | 2,129 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-10-01 | Grant | 3,125 | $0.00 | |
|
GYRE Therapeutics Inc CBIO
Common Stock
|
2020-07-01 | Grant | 2,129 | $0.00 | |
| showing 20 of 66 most recent transactions | |||||